Kristin Raphel

Kristin Raphel

Auto-generated profile, based on publicly available information

Kristin Raphel

Department Emergency Medicine, George Washington University School of Medicine, Washington, DC, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2022 in Cell Reports
Verified
Journal Article
Open access
TNTara M. Narowski
Tara M. Narowski
KRKristin Raphel
Kristin Raphel
LALily E. Adams
Lily E. Adams
JHJenny Huang
Jenny Huang
NVNadja Alexandra Vielot
Nadja Alexandra Vielot
PLPremkumar Lakshmanane
Premkumar Lakshmanane
Understanding vaccine-mediated protection against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is critical to overcoming the global coronavirus disease 2019 (COVID-19) pandemic. We investigate mRNA-vaccine-induced antibody responses against the reference strain, seven variants, and seasonal coronaviruses in 168 healthy individuals at three time points: before vaccination, after the first dose, and after the second dose. Following complete vaccination, both naive and previously infected individuals developed comparably robust SARS-CoV-2 spike antibodies and variable levels of cross-reactive antibodies to seasonal coronaviruses. However, the strength and frequency of SARS-CoV-2 neutralizing antibodies in naive individuals were lower than in previously infected individuals. After the first vaccine dose, one-third of previously infected individuals lacked neutralizing antibodies; this was improved to one-fifth after the second dose. In all individuals, neutralizing antibody responses against the Alpha and Delta variants were weaker than against the reference strain. Our findings support future tailored vaccination strategies against emerging SARS-CoV-2 variants as mRNA-vaccine-induced neutralizing antibodies are highly variable among individuals.

20 November 2023
Verified
Conference Paper
Open access
NSNatalie Sullivan
Natalie Sullivan
KRKristin Raphel
Kristin Raphel
Cybersecurity hazards pose a myriad of threats to hospital function and continuity. With high technological integration, historically poor cyber defense, and potentially catastrophic consequences of compromise, healthcare systems are particularly vulnerable to cyberattack. Often discussions of cybersecurity attacks on healthcare systems focus on electronic medical record (EMR) breach and the disclosure of private medical information. While protecting fundamental privacy rights is vital to patient trust, the effects of cybersecurity on hospital systems extend beyond EMR. This paper outlines the broad range of potential impact that cyberattacks may have on a healthcare system. It discusses the individual downstream consequences of clinical care challenges, the vulnerability of hospital critical infrastructure and the system-wide ramifications of impaired hospital IT infrastructure. From the perspective of clinical care provision, as well as emergency management, we leverage available literature to demonstrate how communication disruption, water supply malfunction, electrical failure, and transportation interruption impact individual patient care, hospital operations, and overall healthcare system functions.

14 June 2024 in Science Advances
Verified
Journal Article
Open access
MMMichael Mallory
Michael Mallory
JMJennifer E. Munt
Jennifer E. Munt
TNTara M. Narowski
Tara M. Narowski
ICIzabella Castillo
Izabella Castillo
ECEdwing Cuadra
Edwing Cuadra
PLPremkumar Lakshmanane
Premkumar Lakshmanane
The recommended COVID-19 booster vaccine uptake is low. At-home lateral flow assay (LFA) antigen tests are widely accepted for detecting infection during the pandemic. Here, we present the feasibility and potential benefits of using LFA-based antibody tests as a means for individuals to detect inadequate immunity and make informed decisions about COVID-19 booster immunization. In a health care provider cohort, we investigated the changes in the breadth and depth of humoral and T cell immune responses following mRNA vaccination and boosting in LFA-positive and LFA-negative antibody groups. We show that negative LFA antibody tests closely reflect the lack of functional humoral immunity observed in a battery of sophisticated immune assays, while positive results do not necessarily reflect adequate immunity. After booster vaccination, both groups gain depth and breadth of systemic antibodies against evolving SARS-CoV-2 and related viruses. Our findings show that LFA-based antibody tests can alert individuals about inadequate immunity against COVID-19, thereby increasing booster shots and promoting herd immunity.